ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2798

Expanded T-Cell Clones Are Present in the Synovium before the Clinical Onset of Rheumatoid Arthritis

Giulia Balzaretti1,2,3, Paul L. Klarenbeek4, Marieke E. Doorenspleet5, Maria JH de Hair6, Barbera C.D. van Schaik7, Rebecca Esveldt2, Marleen van de Sande1, Danielle Gerlag8, Antoine H.C. van Kampen7, Frank Baas2,9, Paul-Peter Tak10 and Niek de Vries3,5, 1Clinical Immunology & Rheumatology, ARC | Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 2Dept. of Genome Analysis, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 3Dept. of Experimental Immunology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 4Amsterdam Rheumatology & immunology Center | Department of Experimental Immunology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 5Amsterdam Rheumatology and immunology Center | Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, 6Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, the Netherlands, Utrecht, Netherlands, 7Bioinformatics Laboratory, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 8GlaxoSmithKline, Stevenage, United Kingdom, 9Dept. of Genome Diagnostics, Leiden University, Leiden, Netherlands, 10GlaxoSmithKline, Cambridge, United Kingdom

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: rheumatoid arthritis (RA) and rheumatoid arthritis, synovium, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: 5T092 ACR Abstract: T Cell Biology & Targets in Autoimmune & Inflammatory Disease (2797–2801)

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:

In healthy individuals with arthralgia and RA-specific autoantibodies (so called at-risk individuals) the presence of expanded B-cell receptor (BCR) clones in peripheral blood (PB) accurately predicts who will develop arthritis in the short term1. Following up on these observations, we investigated in the same cohort of at-risk individuals whether the T-cell receptor beta (TCRβ) repertoire characteristics in PB and synovial tissue (ST) might also predict imminent onset of arthritis.

Methods:

Next-Generation Sequencing of the TCRβ repertoire was performed on 20 randomly selected individuals with elevated IgM-RF and/or ACPA levels. Ten individuals did not develop RA during at least 3 years of follow-up, and 10 individuals did. Peripheral blood and synovial tissue samples were analysed during the at-risk phase and, for individuals that developed RA, again after RA onset. T-cell clones were identified by their unique TCRβ sequence2.

Results:

In the at-risk phase, the synovium is already characterized by expanded TCRβ clones, both in at-risk individuals that will and will not develop arthritis later. These clones persist in the tissue during onset of arthritis. A higher impact of the dominant TCRβ clones in the synovial tissue in the at-risk phase was associated with longer time to arthritis (p=0.02).

Conclusion:

Expanded T-cell clones are present in the synovium of at-risk individuals regardless of future development of RA. The expanded clones are maintained after onset of clinical disease. Combined with literature data, these observations show that T cell clones are already expanded in ST very early in disease, and suggest an overall regulatory role. Further studies are needed to characterize these clones.

References:

1Tak PP et al. Ann Rheum Dis. 2017.

2Klarenbeek PL et al. Immunol Lett. 2010.


Disclosure: G. Balzaretti, None; P. L. Klarenbeek, None; M. E. Doorenspleet, None; M. J. de Hair, None; B. C. D. van Schaik, None; R. Esveldt, None; M. van de Sande, None; D. Gerlag, None; A. H. C. van Kampen, None; F. Baas, None; P. P. Tak, None; N. de Vries, None.

To cite this abstract in AMA style:

Balzaretti G, Klarenbeek PL, Doorenspleet ME, de Hair MJ, van Schaik BCD, Esveldt R, van de Sande M, Gerlag D, van Kampen AHC, Baas F, Tak PP, de Vries N. Expanded T-Cell Clones Are Present in the Synovium before the Clinical Onset of Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/expanded-t-cell-clones-are-present-in-the-synovium-before-the-clinical-onset-of-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/expanded-t-cell-clones-are-present-in-the-synovium-before-the-clinical-onset-of-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology